Global Gastrointestinal Drugs Market Insights and Forecast to 2026

Global Gastrointestinal Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Gastrointestinal Drugs Product Introduction
1.2 Market Segments
1.3 Key Gastrointestinal Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type
1.4.2 Prescription Gastrointestinal Drug
1.4.3 OTC Gastrointestinal Drug
1.5 Market by Application
1.5.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application
1.5.2 Chronic Gastritis
1.5.3 Functional Dyspepsia
1.5.4 Peptic Ulcer
1.5.5 Acute Gastroenteritis
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Drugs Market Size, Estimates and Forecasts
2.1.1 Global Gastrointestinal Drugs Revenue 2015-2026
2.1.2 Global Gastrointestinal Drugs Sales 2015-2026
2.2 Global Gastrointestinal Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Gastrointestinal Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gastrointestinal Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Gastrointestinal Drugs Competitor Landscape by Players
3.1 Gastrointestinal Drugs Sales by Manufacturers
3.1.1 Gastrointestinal Drugs Sales by Manufacturers (2015-2020)
3.1.2 Gastrointestinal Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Gastrointestinal Drugs Revenue by Manufacturers
3.2.1 Gastrointestinal Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Gastrointestinal Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastrointestinal Drugs Revenue in 2019
3.2.5 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gastrointestinal Drugs Price by Manufacturers
3.4 Gastrointestinal Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal Drugs Market Size by Type (2015-2020)
4.1.1 Global Gastrointestinal Drugs Sales by Type (2015-2020)
4.1.2 Global Gastrointestinal Drugs Revenue by Type (2015-2020)
4.1.3 Gastrointestinal Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastrointestinal Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastrointestinal Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Gastrointestinal Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Gastrointestinal Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastrointestinal Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal Drugs Market Size by Application (2015-2020)
5.1.1 Global Gastrointestinal Drugs Sales by Application (2015-2020)
5.1.2 Global Gastrointestinal Drugs Revenue by Application (2015-2020)
5.1.3 Gastrointestinal Drugs Price by Application (2015-2020)
5.2 Gastrointestinal Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastrointestinal Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Gastrointestinal Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastrointestinal Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Gastrointestinal Drugs by Country
6.1.1 North America Gastrointestinal Drugs Sales by Country
6.1.2 North America Gastrointestinal Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gastrointestinal Drugs Market Facts & Figures by Type
6.3 North America Gastrointestinal Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Gastrointestinal Drugs by Country
7.1.1 Europe Gastrointestinal Drugs Sales by Country
7.1.2 Europe Gastrointestinal Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastrointestinal Drugs Market Facts & Figures by Type
7.3 Europe Gastrointestinal Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal Drugs by Region
8.1.1 Asia Pacific Gastrointestinal Drugs Sales by Region
8.1.2 Asia Pacific Gastrointestinal Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Type
8.3 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Gastrointestinal Drugs by Country
9.1.1 Latin America Gastrointestinal Drugs Sales by Country
9.1.2 Latin America Gastrointestinal Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gastrointestinal Drugs Market Facts & Figures by Type
9.3 Central & South America Gastrointestinal Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal Drugs by Country
10.1.1 Middle East and Africa Gastrointestinal Drugs Sales by Country
10.1.2 Middle East and Africa Gastrointestinal Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Gastrointestinal Drugs Products Offered
11.1.5 AstraZeneca Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Gastrointestinal Drugs Products Offered
11.2.5 Sanofi Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description and Business Overview
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Gastrointestinal Drugs Products Offered
11.3.5 Bayer Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Gastrointestinal Drugs Products Offered
11.4.5 Pfizer Related Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Description and Business Overview
11.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Gastrointestinal Drugs Products Offered
11.5.5 GlaxoSmithKline Related Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Description and Business Overview
11.6.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Gastrointestinal Drugs Products Offered
11.6.5 Teva Related Developments
11.7 Zeria(Tillotts)
11.7.1 Zeria(Tillotts) Corporation Information
11.7.2 Zeria(Tillotts) Description and Business Overview
11.7.3 Zeria(Tillotts) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Zeria(Tillotts) Gastrointestinal Drugs Products Offered
11.7.5 Zeria(Tillotts) Related Developments
11.8 Perrigo
11.8.1 Perrigo Corporation Information
11.8.2 Perrigo Description and Business Overview
11.8.3 Perrigo Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Perrigo Gastrointestinal Drugs Products Offered
11.8.5 Perrigo Related Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Description and Business Overview
11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Boehringer Ingelheim Gastrointestinal Drugs Products Offered
11.9.5 Boehringer Ingelheim Related Developments
11.10 Purdue Pharma
11.10.1 Purdue Pharma Corporation Information
11.10.2 Purdue Pharma Description and Business Overview
11.10.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Purdue Pharma Gastrointestinal Drugs Products Offered
11.10.5 Purdue Pharma Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Gastrointestinal Drugs Products Offered
11.1.5 AstraZeneca Related Developments
11.12 Abbott
11.12.1 Abbott Corporation Information
11.12.2 Abbott Description and Business Overview
11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Abbott Products Offered
11.12.5 Abbott Related Developments
11.13 Jiangzhong
11.13.1 Jiangzhong Corporation Information
11.13.2 Jiangzhong Description and Business Overview
11.13.3 Jiangzhong Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Jiangzhong Products Offered
11.13.5 Jiangzhong Related Developments
11.14 Xian-Janssen
11.14.1 Xian-Janssen Corporation Information
11.14.2 Xian-Janssen Description and Business Overview
11.14.3 Xian-Janssen Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Xian-Janssen Products Offered
11.14.5 Xian-Janssen Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Gastrointestinal Drugs Market Estimates and Projections by Region
12.1.1 Global Gastrointestinal Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Gastrointestinal Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Gastrointestinal Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Gastrointestinal Drugs Sales Forecast (2021-2026)
12.2.2 North America: Gastrointestinal Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Gastrointestinal Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Gastrointestinal Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Gastrointestinal Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gastrointestinal Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gastrointestinal Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gastrointestinal Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gastrointestinal Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Gastrointestinal Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Gastrointestinal Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Gastrointestinal Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gastrointestinal Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gastrointestinal Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gastrointestinal Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Gastrointestinal Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Gastrointestinal Drugs Market Segments
Table 2. Ranking of Global Top Gastrointestinal Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastrointestinal Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Prescription Gastrointestinal Drug
Table 5. Major Manufacturers of OTC Gastrointestinal Drug
Table 6. Global Gastrointestinal Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Gastrointestinal Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Gastrointestinal Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Gastrointestinal Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Gastrointestinal Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Gastrointestinal Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Gastrointestinal Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Drugs as of 2019)
Table 15. Gastrointestinal Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Gastrointestinal Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Gastrointestinal Drugs Price (2015-2020) (USD/Unit)
Table 18. Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Gastrointestinal Drugs Product Type
Table 20. Date of International Manufacturers Enter into Gastrointestinal Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Gastrointestinal Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Gastrointestinal Drugs Sales Share by Type (2015-2020)
Table 24. Global Gastrointestinal Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Gastrointestinal Drugs Revenue Share by Type (2015-2020)
Table 26. Gastrointestinal Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Gastrointestinal Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Gastrointestinal Drugs Sales Share by Application (2015-2020)
Table 29. North America Gastrointestinal Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Gastrointestinal Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Gastrointestinal Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Gastrointestinal Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Gastrointestinal Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Gastrointestinal Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Gastrointestinal Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Gastrointestinal Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Gastrointestinal Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Gastrointestinal Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Gastrointestinal Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Gastrointestinal Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Gastrointestinal Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Gastrointestinal Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Gastrointestinal Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Gastrointestinal Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Gastrointestinal Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Gastrointestinal Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Gastrointestinal Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Gastrointestinal Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Gastrointestinal Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Gastrointestinal Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Gastrointestinal Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Gastrointestinal Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Gastrointestinal Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Gastrointestinal Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Gastrointestinal Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Gastrointestinal Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Gastrointestinal Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Gastrointestinal Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Gastrointestinal Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Gastrointestinal Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Gastrointestinal Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Gastrointestinal Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Application (2015-2020)
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Description and Major Businesses
Table 71. AstraZeneca Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. AstraZeneca Product
Table 73. AstraZeneca Recent Development
Table 74. Sanofi Corporation Information
Table 75. Sanofi Description and Major Businesses
Table 76. Sanofi Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Sanofi Product
Table 78. Sanofi Recent Development
Table 79. Bayer Corporation Information
Table 80. Bayer Description and Major Businesses
Table 81. Bayer Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Bayer Product
Table 83. Bayer Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. GlaxoSmithKline Corporation Information
Table 90. GlaxoSmithKline Description and Major Businesses
Table 91. GlaxoSmithKline Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Recent Development
Table 94. Teva Corporation Information
Table 95. Teva Description and Major Businesses
Table 96. Teva Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Teva Product
Table 98. Teva Recent Development
Table 99. Zeria?Tillotts? Corporation Information
Table 100. Zeria?Tillotts? Description and Major Businesses
Table 101. Zeria?Tillotts? Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Zeria?Tillotts? Product
Table 103. Zeria?Tillotts? Recent Development
Table 104. Perrigo Corporation Information
Table 105. Perrigo Description and Major Businesses
Table 106. Perrigo Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Perrigo Product
Table 108. Perrigo Recent Development
Table 109. Boehringer Ingelheim Corporation Information
Table 110. Boehringer Ingelheim Description and Major Businesses
Table 111. Boehringer Ingelheim Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Boehringer Ingelheim Product
Table 113. Boehringer Ingelheim Recent Development
Table 114. Purdue Pharma Corporation Information
Table 115. Purdue Pharma Description and Major Businesses
Table 116. Purdue Pharma Gastrointestinal Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Purdue Pharma Product
Table 118. Purdue Pharma Recent Development
Table 119. C.B. Fleet Corporation Information
Table 120. C.B. Fleet Description and Major Businesses
Table 121. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. C.B. Fleet Product
Table 123. C.B. Fleet Recent Development
Table 124. Abbott Corporation Information
Table 125. Abbott Description and Major Businesses
Table 126. Abbott Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Abbott Product
Table 128. Abbott Recent Development
Table 129. Jiangzhong Corporation Information
Table 130. Jiangzhong Description and Major Businesses
Table 131. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Jiangzhong Product
Table 133. Jiangzhong Recent Development
Table 134. Xian-Janssen Corporation Information
Table 135. Xian-Janssen Description and Major Businesses
Table 136. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Xian-Janssen Product
Table 138. Xian-Janssen Recent Development
Table 139. Global Gastrointestinal Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 140. Global Gastrointestinal Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Gastrointestinal Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Gastrointestinal Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Gastrointestinal Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 144. North America: Gastrointestinal Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Gastrointestinal Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 146. Europe: Gastrointestinal Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Gastrointestinal Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 148. Asia Pacific: Gastrointestinal Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Gastrointestinal Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 150. Latin America: Gastrointestinal Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Gastrointestinal Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 152. Middle East and Africa: Gastrointestinal Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Gastrointestinal Drugs Players
Table 157. Gastrointestinal Drugs Customers List
Table 158. Gastrointestinal Drugs Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal Drugs Product Picture
Figure 2. Global Gastrointestinal Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Prescription Gastrointestinal Drug Product Picture
Figure 4. OTC Gastrointestinal Drug Product Picture
Figure 5. Global Gastrointestinal Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Chronic Gastritis
Figure 7. Functional Dyspepsia
Figure 8. Peptic Ulcer
Figure 9. Acute Gastroenteritis
Figure 10. Other
Figure 11. Gastrointestinal Drugs Report Years Considered
Figure 12. Global Gastrointestinal Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Gastrointestinal Drugs Sales 2015-2026 (K Units)
Figure 14. Global Gastrointestinal Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Gastrointestinal Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Gastrointestinal Drugs Sales Market Share by Region in 2019
Figure 17. Global Gastrointestinal Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Gastrointestinal Drugs Revenue Market Share by Region in 2019
Figure 19. Global Gastrointestinal Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Gastrointestinal Drugs Revenue in 2019
Figure 21. Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Gastrointestinal Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Gastrointestinal Drugs Sales Market Share by Type in 2019
Figure 24. Global Gastrointestinal Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Gastrointestinal Drugs Revenue Market Share by Type in 2019
Figure 26. Global Gastrointestinal Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Gastrointestinal Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Gastrointestinal Drugs Sales Market Share by Application in 2019
Figure 29. Global Gastrointestinal Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Gastrointestinal Drugs Revenue Market Share by Application in 2019
Figure 31. North America Gastrointestinal Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Gastrointestinal Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Gastrointestinal Drugs Sales Market Share by Country in 2019
Figure 34. North America Gastrointestinal Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Gastrointestinal Drugs Market Share by Type in 2019
Figure 40. North America Gastrointestinal Drugs Market Share by Application in 2019
Figure 41. Europe Gastrointestinal Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Gastrointestinal Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Gastrointestinal Drugs Sales Market Share by Country in 2019
Figure 44. Europe Gastrointestinal Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Gastrointestinal Drugs Market Share by Type in 2019
Figure 56. Europe Gastrointestinal Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Gastrointestinal Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Gastrointestinal Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region in 2019
Figure 61. China Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Gastrointestinal Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Gastrointestinal Drugs Market Share by Application in 2019
Figure 85. Latin America Gastrointestinal Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Gastrointestinal Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Gastrointestinal Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Gastrointestinal Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Un

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs